These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites. Yakovlev S, Makogonenko E, Kurochkina N, Nieuwenhuizen W, Ingham K, Medved L. Biochemistry; 2000 Dec 26; 39(51):15730-41. PubMed ID: 11123898 [Abstract] [Full Text] [Related]
5. Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids). Siebenlist KR, Mosesson MW, Meh DA, DiOrio JP, Albrecht RM, Olson JD. Blood Coagul Fibrinolysis; 2000 Apr 26; 11(3):293-304. PubMed ID: 10870810 [Abstract] [Full Text] [Related]
9. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II). Kamijyo Y, Hirota-Kawadobora M, Yamauchi K, Terasawa F, Honda T, Ikeya M, Okumura N. Blood Coagul Fibrinolysis; 2009 Dec 26; 20(8):726-32. PubMed ID: 19809304 [Abstract] [Full Text] [Related]
10. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase. Okada K, Ueshima S, Takaishi T, Yuasa H, Fukao H, Matsuo O. Am J Hematol; 1996 Nov 26; 53(3):151-7. PubMed ID: 8895684 [Abstract] [Full Text] [Related]
13. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN. Dempfle CE, Dollman M, Lill H, Puzzovio D, Dessauer A, Heene DL. Blood Coagul Fibrinolysis; 1993 Feb 26; 4(1):79-86. PubMed ID: 8457657 [Abstract] [Full Text] [Related]
20. The structure and biological features of fibrinogen and fibrin. Mosesson MW, Siebenlist KR, Meh DA. Ann N Y Acad Sci; 2001 Apr 22; 936():11-30. PubMed ID: 11460466 [Abstract] [Full Text] [Related] Page: [Next] [New Search]